Benefits of Alpha-Stim
Lila Massoumi, MD
Chairperson, Caucus on Complementary, Alternative, and Integrative Medicine, American Psychiatric Association
Dr. Massoumi has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Read More
Daniel Carlat, MD.
Editor-in-Chief, Publisher, The Carlat Report.
Rajnish Mago, MD
Director, Mood Disorders Program, Associate Professor of Psychiatry, Thomas Jefferson University
Dr. Mago discloses that he has received research grants from Alkermes, Allergan (formerly Forest Laboratories), Genomind, and Takeda, and that he has been a paid consultant to Genomind, Guidepoint Global, Otsuka, and Lundbeck. Dr. Carlat has reviewed this article and found no evidence of bias in this educational activity.
Bret A. Moore, PsyD, ABPP. Board-Certified Clinical Psychologist, San Antonio, TX

_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747)



